GLP-1 MenDispatch
Hormones ยท Body Composition

GLP-1 vs TRT for Belly Fat: Which Moves the Needle?

Two of the most powerful pharmacological tools for men's body composition โ€” compared head-to-head. Different mechanisms, different trade-offs, and the case for combining them.

๐Ÿ“… May 2026 ยท โฑ 8 min ยท ๐Ÿ”ฌ Clinical comparison

If you're a man over 35 carrying visceral belly fat, you've probably looked at two options: testosterone replacement therapy (TRT) and GLP-1 medications. Both have robust clinical evidence. Both reduce body fat. And both are increasingly accessible through telehealth. But they work through completely different mechanisms โ€” and the right choice depends on what's actually driving your problem.

How Each One Works

TRT restores testosterone levels to the normal physiological range (typically 450โ€“900 ng/dL for adult men). Low testosterone is associated with increased visceral adiposity, decreased lean mass, insulin resistance, and fatigue. TRT reverses these effects by normalizing hormonal signaling. It doesn't directly suppress appetite โ€” it shifts metabolic partitioning so your body preferentially builds muscle and burns fat.

GLP-1 medications (semaglutide, tirzepatide) work through the incretin system. They suppress appetite via hypothalamic signaling, slow gastric emptying, improve insulin sensitivity, and reduce visceral fat through sustained caloric deficit. They don't directly affect testosterone โ€” though ENDO 2025 data showed that 77% of obese men on GLP-1 therapy normalized testosterone levels as a downstream effect of weight loss.

The Numbers: Head-to-Head

MetricTRTGLP-1 (Semaglutide 2.4mg)
Total body weight lossMinimal (0โ€“3%)Significant (10โ€“17%)
Visceral fat reductionModerate (DEXA studies show 5โ€“15%)Substantial (20โ€“30%+ in trials)
Lean mass effectIncreases (+2โ€“5 lbs typical)Decreases (35โ€“40% of weight lost)
Testosterone impactDirectly normalizesIndirectly improves via weight loss
Appetite effectMinimalStrong suppression
Cardiovascular evidenceMixed (some risk signals)Positive (SELECT trial)
Fertility impactSuppresses spermatogenesisMay improve (ENDO data)
Typical monthly cost$80โ€“$200$150โ€“$400 (compounded)
77% Percentage of obese men on GLP-1 therapy who normalized testosterone levels without TRT, per ENDO 2025 data. Weight loss alone restored hormonal function in the majority of cases.

When to Choose GLP-1

Your primary problem is excess weight. If you're carrying 30+ lbs of excess fat, GLP-1 medications will produce faster, more dramatic body composition changes than TRT. The weight loss alone may normalize your testosterone, as the ENDO data showed.

You want cardiovascular protection. The SELECT trial demonstrated that semaglutide reduced major adverse cardiovascular events by 20% in obese adults. TRT's cardiovascular profile is more complicated โ€” some studies show benefit, others show risk, and the long-term data is less clear.

Fertility matters. TRT suppresses spermatogenesis. If you're planning to have children, GLP-1 is the safer choice โ€” and may actually improve fertility by reducing the metabolic dysfunction that impairs reproductive function.

When to Choose TRT

You have confirmed low testosterone. If blood work shows total testosterone below 300 ng/dL (or free testosterone below the normal range) with symptoms โ€” fatigue, low libido, brain fog, depressed mood โ€” TRT addresses the root cause directly. GLP-1 medication is not a testosterone replacement.

Lean mass is the priority. TRT builds muscle. GLP-1 medications can cause muscle loss. If you're already lean-ish but weak and hormonally depleted, TRT is the more targeted intervention.

You don't have significant weight to lose. If your BMI is 27 and your issue is body composition (too much fat, too little muscle) rather than total body weight, TRT's anabolic effects may be more relevant than GLP-1's weight loss effects.

The Case for Both

Here's where it gets interesting. For men with obesity AND confirmed low testosterone, the combination is pharmacologically logical: GLP-1 handles the weight loss and metabolic improvement. TRT handles muscle preservation and hormonal optimization. They don't compete โ€” they're complementary.

No large-scale randomized trial has studied this specific combination yet, but the mechanistic case is strong and clinical practice is increasingly moving in this direction. If you're considering both, work with a provider who understands male hormone optimization and can monitor your bloodwork appropriately โ€” testosterone, hematocrit, PSA, lipids, and metabolic markers.

Providers for Men's Optimization

โš ๏ธ FDA Notice: Compounded medications are not FDA-approved. Consult a licensed healthcare provider for hormone testing and treatment decisions.

TMates

GLP-1 + TRT programs ยท Men's multi-vertical telehealth ยท $250 CPA

View Program โ†’

Eden Health

GLP-1 programs ยท Brand-name Zepbound available ยท Clinical support

View Program โ†’

Strut Health

Men's weight loss ยท Injectable + sublingual GLP-1 options ยท From $125

View Program โ†’

Bottom Line

GLP-1 medications are the stronger tool for reducing total body weight and visceral belly fat. TRT is the stronger tool for building lean mass and restoring hormonal function. If your testosterone is low primarily because you're overweight, start with GLP-1 โ€” 77% of men normalized their levels through weight loss alone. If your testosterone is low independent of weight, TRT is the direct intervention. If both apply, the combination addresses both problems simultaneously.

Get your bloodwork done. Know your numbers. Then pick the tool that matches your actual problem.

Sources

  1. ENDO 2025 โ€” GLP-1 agonists and testosterone normalization in obese men (poster presentation)
  2. Lincoff AM et al. โ€” Semaglutide and Cardiovascular Outcomes in Obesity (SELECT trial). N Engl J Med, 2023
  3. Corona G et al. โ€” Testosterone replacement therapy and cardiovascular risk. Eur J Endocrinol, 2021
  4. Saad F et al. โ€” Testosterone therapy and body composition in hypogonadal men. J Clin Endocrinol Metab, 2016
  5. Wilding JPH et al. โ€” STEP 1 body composition sub-analysis. N Engl J Med, 2021
Affiliate Disclosure: GLP-1 Men earns commissions on referrals through links marked "Paid link." Editorial content is independently produced. Compounded medications are not FDA-approved.